Primary Care Implementation Study to Scale up EIBI and Reduce Alcohol Related Negative Outcomes
NCT ID: NCT04398576
Last Updated: 2020-05-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
84 participants
INTERVENTIONAL
2020-07-01
2022-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of a Health Education Program in a Primary Care Setting
NCT00012779
Primary Care Validation in French of a Single-question Screening Test for Unhealthy Alcohol Use.
NCT04329988
Promotion of Healthy Lifestyle Habits in a Primary Care Setting
NCT05689762
Effects of Primary Prevention in Elderly People-The Healthy Aging Initiative
NCT03312439
Problematic Use and Addiction in Primary Care
NCT06580756
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study will last 18 months and will take place in three cities of comparable size. In each area at least 28 GPs will be recruited.
The primary outcome will be the proportion of consulting adult patients screened for hazardous and harmful alcohol use at the end-point of an 18-month implementation period. The secondary outcomes will be the screening rate as assessed at 3, 6, 9, 12 and 15 months and the proportion of patients screening positive for hazardous and harmful alcohol use that receive a brief intervention at 3,6,9, 12, 15 and 18 months. Furthermore, the relation between GP's views and needs and practices' contexts, and EIBI performance will be explored.
Data regarding screening and brief intervention activities will be collected from the electronic health records (EHR).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Support as usual
There will be no interventions, only support as usual. All GPs receive an information package by post or via e-mail containing:
* Belgian guidelines on the management of hazardous and harmful alcohol use
* A summary card about EIBI for hazardous and harmful alcohol consumption.
* Internet links to documentation of the medical association and the Flemish centre of expertise on alcohol and drugs(31).
An EHR-update allows the use of an extra e-form permitting standardised introduction of screening results from the Alcohol Use Disorders Identification Test (-Consumption) (AUDIT(-C)), alcohol-related diagnoses and actions including provision of oral brief advice/intervention, referral to a digital-based system for advice and/or referral to another health care provider.
No interventions assigned to this group
Training and support
All GPs receive an information package by post or via e-mail containing:
* Belgian guidelines on the management of hazardous and harmful alcohol use
* A summary card about EIBI for hazardous and harmful alcohol consumption.
* Internet links to documentation of the medical association and the Flemish centre of expertise on alcohol and drugs(31).
An EHR-update allows the use of an extra e-form permitting standardised introduction of screening results from the Alcohol Use Disorders Identification Test (-Consumption) (AUDIT(-C)), alcohol-related diagnoses and actions including provision of oral brief advice/intervention, referral to a digital-based system for advice and/or referral to another health care provider.
There shall be tailored training and support for the general practioners. At the start of the study, this group receives two face-to-face educational trainings of two hours each. Another two face-to-face booster sessions will follow at 6 and at 12 months.
Training and support
GP's receive the tools to make early identification of harmful and hazardous alcohol use possible. They are given guidelines to apply a brief intervention. At the start of the study, the T\&S-group receives two face-to-face educational trainings of two hours each. Another two face-to-face booster sessions will follow at 6 and at 12 months.
Training and support and community actions
In this group, GPs receive the same training and support as in the second arm (training and support). There will also be embedded community-based actions within a local strategy.
Training and support
GP's receive the tools to make early identification of harmful and hazardous alcohol use possible. They are given guidelines to apply a brief intervention. At the start of the study, the T\&S-group receives two face-to-face educational trainings of two hours each. Another two face-to-face booster sessions will follow at 6 and at 12 months.
Community actions
There will be embedded community-based actions within a local strategy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Training and support
GP's receive the tools to make early identification of harmful and hazardous alcohol use possible. They are given guidelines to apply a brief intervention. At the start of the study, the T\&S-group receives two face-to-face educational trainings of two hours each. Another two face-to-face booster sessions will follow at 6 and at 12 months.
Community actions
There will be embedded community-based actions within a local strategy.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Dutch language use in practice
* Working in general practice in 3 cities of comparable size or their sub municipalities
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cathy Matheï
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cathy Matheï, master
Role: PRINCIPAL_INVESTIGATOR
professor
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Pussig B, Pas L, Li A, Vermandere M, Aertgeerts B, Mathei C. Primary care implementation study to scale up early identification and brief intervention and reduce alcohol-related negative outcomes at the community level (PINO): study protocol for a quasi-experimental 3-arm study. BMC Fam Pract. 2021 Jul 1;22(1):144. doi: 10.1186/s12875-021-01479-9.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
s63342
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.